Business Daily from THE HINDU group of publications
Wednesday, Aug 30, 2006

Cross Currency

Group Sites

Corporate - Alliances & Joint Ventures
Suven, Eli Lilly in pact for pre-clinical research

Our Bureau

Hyderabad , Aug. 29

Suven Life Sciences Ltd announced on Tuesday that it has signed an agreement with the US pharma major Eli Lilly & Company to collaborate on pre-clinical research of molecules in the therapeutic area of central nervous system (CNS) disorders.

In a press release here, the Suven Vice-President, Drug Discovery, Dr Ramakrishna Nirogi, said, "This effort is a collaboration between Suven and Lilly, with scientists from both parties working together in a team, with the goal of identifying potent, oral compounds that selectively modulate the specified G-Protein Coupled Receptor for the target CNS disease."

In terms of the deal, Suven would receive payments from Lilly and potentially downstream payments if the identified candidates were selected by Lilly for further pre-clinical research and development.

The Suven Vice-Chairman and CEO, Mr Venkat Jasti, termed this as the company's first true research collaboration with a global pharmaceutical company. He expects this to help the company realise the next step of its vision.

With the in-house capabilities and drug discovery and development support services expertise, Suven has generated a diverse pipeline of drug candidates in CNS that are in various phases of pre-clinical development, the release said.

More Stories on : Alliances & Joint Ventures | Pharmaceuticals | Research & Development

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
BHEL to invest Rs 1,600 cr for capacity expansion

TNAU, Rasi Seeds in pact
ETC to buy back shares
Nagarjuna bags Rs 114-cr order
Sheths hike stake in GE Shipping
Global Green acquires Belgium co
`Essel Propack buys Packaging India'
Ispat Industries to set up 3-mt pelletisation plant in Vizag
Gulshan Sugars' first phase expansion may get over by Nov
Pitti Laminations' new plant
No tax sops for export of capital
Strides gets USFDA nod for AIDS drug Stavudine
Lock-out at Doom Dooma Tea division
Plea to expedite decision on BHPV revival package
Suven, Eli Lilly in pact for pre-clinical research
Aerostar-FSA pact for pilot training
Rolls-Royce plans MoU with HAL
SBI, VRS Foods sign pact
BharatMatrimony turns to brick-and-mortar
KPFC to diversify
BIFR to hold review hearing on Metal Box
GAIL may set up coal gasification plant in East
`Parryware unfazed by foreign competition'
Cryo Stemcell plans to foray into consultancy, training space
New GM for NTPC
Rami Reddy to head BHEL unit

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line